ArticleAmerican heart journal plus : cardiology research and practice2026
Outcomes of isolated ostial LAD PCI versus multivessel PCI including ostial LAD lesions.
Article in American heart journal plus : cardiology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ostial lesions of the left anterior descending (LAD) coronary artery are critical targets for revascularization due to their role in supplying a large portion of the myocardium, and are often accompanied by multivessel disease, complicating treatment planning and prognosis. Methods: This was a retrospective, single-center study. Patients with ostial LAD PCI isolated or in conjunction with PCI in another vessel were included and were grouped into isolated ostial LAD PCI ( Results: Participants undergoing multivessel PCI were significantly older, with a median age of 70 years (IQR: 62-77), compared to 68 years (IQR: 59-75) in the isolated ostial LAD PCI group ( Conclusion: In patients undergoing ostial LAD PCI, treatment of an additional vessel did not increase the risk of MACE in long-term follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.